Literature DB >> 17479544

Analysis of the in vitro metabolites of diferuloylmethane (curcumin) by liquid chromatography--tandem mass spectrometry on a hybrid quadrupole linear ion trap system: newly identified metabolites.

Constantin Tamvakopoulos1, Zacharias D Sofianos, Spiros D Garbis, Panayotis Pantazis.   

Abstract

In this study, we have described a novel approach for determining the metabolic scheme of diferuloylmethane (curcumin) in mouse and human liver microsomal preparations using a hybrid quadrupole linear ion trap mass spectrometer coupled with liquid chromatography for the detection of new metabolites. Application of various acquisition modes allowed targeted searches for metabolites with high sensitivity and selectivity using information of the mass spectral fragmentation properties of curcumin. Structural assignments for metabolites previously reported in the literature were made with confidence using the described approach. In addition, we identified curcumin metabolites that had not previously been reported, such as curcumin bisglucuronide and O-demethylated derivatives. The major pathways of curcumin metabolism in vitro have been summarized. Finally, very similar metabolic pathways of curcumin were observed in human and mouse microsomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479544     DOI: 10.1007/BF03190990

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  19 in total

1.  Use of a quadrupole linear ion trap mass spectrometer in metabolite identification and bioanalysis.

Authors:  Yuan-Qing Xia; Jeffrey D Miller; Ray Bakhtiar; Ronald B Franklin; David Q Liu
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

2.  Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer.

Authors:  Gérard Hopfgartner; Christophe Husser; Manfred Zell
Journal:  J Mass Spectrom       Date:  2003-02       Impact factor: 1.982

3.  Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Authors:  R A Sharma; H R McLelland; K A Hill; C R Ireson; S A Euden; M M Manson; M Pirmohamed; L J Marnett; A J Gescher; W P Steward
Journal:  Clin Cancer Res       Date:  2001-07       Impact factor: 12.531

Review 4.  The use of Qtrap technology in drug metabolism.

Authors:  Richard King; Carmen Fernandez-Metzler
Journal:  Curr Drug Metab       Date:  2006-06       Impact factor: 3.731

5.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

6.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Authors:  C Ireson; S Orr; D J Jones; R Verschoyle; C K Lim; J L Luo; L Howells; S Plummer; R Jukes; M Williams; W P Steward; A Gescher
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems.

Authors:  Stefan Gafner; Sang-Kook Lee; Muriel Cuendet; Sophie Barthélémy; Laurent Vergnes; Serge Labidalle; Rajendra G Mehta; Charles W Boone; John M Pezzuto
Journal:  Phytochemistry       Date:  2004-11       Impact factor: 4.072

8.  Curcumin: getting back to the roots.

Authors:  Shishir Shishodia; Gautam Sethi; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

Review 9.  Cell signaling pathways altered by natural chemopreventive agents.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Mutat Res       Date:  2004-11-02       Impact factor: 2.433

10.  Chemopreventive properties of curcumin.

Authors:  Frederick C Campbell; Gavin P Collett
Journal:  Future Oncol       Date:  2005-06       Impact factor: 3.404

View more
  4 in total

1.  A Novel Triple Stage Ion Trap MS method validated for curcumin pharmacokinetics application: A comparison summary of the latest validated curcumin LC/MS methods.

Authors:  Wenji Li; Hilly Yang; Brian Buckley; Lujing Wang; Ah-Ng Kong
Journal:  J Pharm Biomed Anal       Date:  2018-04-17       Impact factor: 3.935

2.  A Curcumin Degradation Product, 7-Norcyclopentadione, Formed by Aryl Migration and Loss of a Carbon from the Heptadienedione Chain.

Authors:  Akil I Joseph; Paula B Luis; Claus Schneider
Journal:  J Nat Prod       Date:  2018-12-18       Impact factor: 4.050

3.  Urine and serum analysis of consumed curcuminoids using an IkappaB-luciferase surrogate marker assay.

Authors:  Sivapriya Ponnurangam; Fadee G Mondalek; Janita Govind; Dharmalingam Subramaniam; Courtney W Houchen; Shrikant Anant; Panayotis Pantazis; Rama P Ramanujam
Journal:  In Vivo       Date:  2010 Nov-Dec       Impact factor: 2.155

4.  Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.

Authors:  Takahiro Harigae; Kiyotaka Nakagawa; Taiki Miyazawa; Nao Inoue; Fumiko Kimura; Ikuo Ikeda; Teruo Miyazawa
Journal:  Int J Nanomedicine       Date:  2016-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.